Hydroxychloroquine for Thrombosis Prevention and Antiphospholipid Antibody Reduction in Primary Antiphospholipid Syndrome
Condition:   Antiphospholipid Syndrome Intervention:   Drug: Hydroxychloroquine Sponsor:   National and Kapodistrian University of Athens Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 6, 2019 Category: Research Source Type: clinical trials